Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Corticosteroids vs Pimecrolimus for Vulvar Lichen Sclerosus
NCT07240389Not yet recruiting
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Open-label trial of platelet-rich plasma injection in vulvar lichen sclerosus (LS) (3 arms). Primary endpoint: Dermatology Life Quality Index at 6 months. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
platelet-rich plasma injection
03
Conditions
vulvar lichen sclerosus (LS)
Beyond the preview
Go deeper on NCT07240389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07240389.